Kapadi
Andrew Bradshaw has a Bachelor of Science in Biological and Biomedical Sciences from The University of Manchester. Andrew has worked in various roles within the clinical research industry, including as a Clinical Research Associate at PRA Health Sciences, UK Director of Clinical Operations at Scope International AG, and Director of Business Development at Clinscience and Kapadi. In their current role at Kapadi, Andrew is responsible for leading business development activities across multiple regions, with a focus on Oncology & Cell & Gene Therapy clinical studies. Andrew has experience in breaking into new territories and establishing successful business connections. Andrew has also played key roles in training programs for CRAs and managing multiple study sites and CRAs simultaneously.
This person is not in any offices
Kapadi
Kapadi (former OncoBay, Clinscience and Exom) delivers specialized biotech Contract Research Organization (CRO) services, expertly navigating the intricacies of early-stage drug development. We harness state-of-the-art technology solutions and advanced data visualization to propel operational and data excellence. Our team's unwavering dedication to the field is evident, with each member bringing deep expertise in oncology, and pioneering areas like gene and cell therapy. At Kapadi, we're committed to accelerating the breakthroughs that will shape the future of cancer treatment.